logo
Global Artificial Intelligence in Oncology Market Size to Hit USD 2,145.1 Million by 2025, grow at a CAGR of 33.7%

Global Artificial Intelligence in Oncology Market Size to Hit USD 2,145.1 Million by 2025, grow at a CAGR of 33.7%

Globe and Mail14-07-2025
Artificial intelligence (AI) is playing an increasingly important role in oncology. There are various types of AI products that are helping in cancer screening, diagnosis, treatment, and drug development. One of the major products is an AI-assisted cancer screening tool. These tools use deep learning algorithms that have been trained on huge databases of medical images.
Global Artificial Intelligence in Oncology Market Key Takeaways
According to Coherent Market Insights (CMI), the global artificial intelligence in oncology market size is expected to grow more than 7.6X, from USD 2,145.1 Mn in 2025 to USD 16,382 Mn by 2032, exhibiting a robust CAGR of 33.7%.
Based on component, software/platform segment is anticipated to account for a prominent market share of 64.2% in 2025.
North America is expected to retain its dominance, accounting for more than one-third of the global artificial intelligence in oncology market share in 2025.
Europe is projected to remain the second-leading market for AI-powered oncology companies.
As per Coherent Market Insights' new global artificial intelligence in oncology market analysis, Asia Pacific is poised to witness fastest growth throughout the assessment period.
Increasing Cancer Prevalence Spurring Market Growth
Coherent Market Insights' latest global artificial intelligence in oncology market research report highlights key factors driving market growth. One such prominent growth factor is the rising incidence of cancer.
The IARC's Global Cancer Observatory projects that annual new cancer cases will surpass 35 million by 2050. This sharp rise in cancer incidence is anticipated to drive demand for artificial intelligence in oncology.
Artificial intelligence is revolutionizing oncology by enhancing cancer detection, treatment planning, and drug discovery. Therefore, growing cancer burden is poised to play a crucial role in driving adoption of AI-based oncology solutions over the forecast period.
High Implementation Costs and Data Privacy Concerns Restraining Market Growth
The global artificial intelligence in oncology market outlook indicates strong future growth. However, high implementation costs and data security concerns are limiting market growth to some extent.
Integrating AI technologies into oncology workflows requires significant investment in hardware and software. This deters small and mid-sized healthcare companies from opting for these technologies, thereby reducing global artificial intelligence in oncology market demand.
AI systems require access to large amounts of patient data, raising concerns about cybersecurity risks as well as potential misuse. This may also negatively impact the global artificial intelligence in oncology market growth during the projection period.
Get Instant Access! Purchase Research Report and Receive a 25% Discount: https://www.coherentmarketinsights.com/insight/buy-now/6509
Technological Advancements in AI Creating New Growth Prospects for the Market
Ongoing innovations in deep learning, computer vision, and natural language processing (NLP) are significantly enhancing AI applications in image analysis, drug discovery, and prognosis prediction. Such breakthroughs are expected to unlock new revenue-generation streams for industry players.
Advanced AI technologies are being increasingly integrated with imaging modalities like MRI and PET scans. This integration enables automated detection of anomalies, enhances diagnostic accuracy, and reduces human error.
Emerging Global Artificial Intelligence in Oncology Market Trends
Rising demand for precision medicine is a key growth-shaping trend in the market. Precision oncology requires analyzing large datasets, including genomics and biomarkers. This is where AI steps in, processing huge data and enabling creation of individualized therapies.
Expanding use of artificial intelligence in radiology and pathology is expected to boost the market. AI technologies are being increasingly used for tumor detection, segmentation, and classification through radiological and histopathological images. This is due to their ability to improve speed and consistency as well as reduce diagnostic errors.
Increasing adoption of AI in drug discovery and development is positively impacting the global artificial intelligence in oncology market value. This advanced technology is revolutionizing drug discovery by rapidly analyzing large datasets to identify potential drug candidates as well as predict their efficacy and toxicity.
Growing adoption of cloud-based AI solutions is significantly contributing to the expansion of the global artificial intelligence in oncology market. These solutions are increasingly favored for their cost-efficiency, scalability, and ability to provide seamless remote access to data and tools.
Analyst's View
' The global artificial intelligence in oncology market is set for rapid expansion, owing to growing prevalence of cancer, rising adoption of precision medicine, and technological advancements in AI technologies,' said senior analyst Komal Dighe.
Current Events and Their Impact on the Global Artificial Intelligence in Oncology Market
Event
Description and Impact
FDA Clears First GenAI-Powered Diagnostic Tool for Breast Cancer Detection (2025)
Description: The U.S. FDA approved a GenAI-based diagnostic platform by PathIntel, capable of identifying breast cancer subtypes with high accuracy using real-world data.
Impact: Such approvals signal growing regulatory acceptance of generative AI in oncology.
Tempus Collaborated with Boehringer to Accelerate AI Usage in Oncology
Description: In May 2025, Tempus entered a multi-year strategic collaboration with Boehringer Ingelheim to apply its AI-driven oncology insights toward cancer‑focused therapeutic discovery and biomarker development
Impact: This will likely boost growth of the AI in oncology market.
Japan's MHLW Updates Reimbursement Guidelines for AI Diagnostics
Description: Japanese Ministry of Health, Labour and Welfare (MHLW) has approved reimbursement for certain AI-enhanced imaging diagnostics
Impact: Such initiatives will increase commercial viability and adoption of AI oncology tools in Asia-Pacific, spurring more localized R&D and product launches.
Competitor Insights
Key companies listed in the global artificial intelligence in oncology market report:
- IBM Corporation
- Intel Corporation
- Azra AI
- NVIDIA Corporation
- Siemens Healthineers AG
- GE HealthCare
- Digital Diagnostics Inc.
- ConcertAI
- PathAI
- Median Technologies
- Microsoft
- Babylon
- Zebra Medical Vision
Key Developments
In June 2025, Viz.ai launched a new strategic alliance with Novartis to accelerate timely diagnosis and deliver AI-powered precision care for cancer patients. Through this collaboration, Viz.ai will focus on developing AI-powered workflows for breast and prostate cancer.
In November 2024, PathAI unveiled PathExplore Fibrosis. This new AI-powered tool is designed to revolutionize collagen, fibrosis, and fiber quantification directly from whole-slide images.
In January 2024, PathAI launched six additional oncology indications for PathExplore, expanding the AI-driven pathology panel to cover ovarian, bladder, liver, small cell lung, lymphoma, and head & neck cancers.
Global Artificial Intelligence in Oncology Market Segmentation:
By Component
Software/Platform
Hardware
Services
By Cancer Type
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Brain Tumor
Others
By Treatment Type
Chemotherapy
Radiotherapy
Immunotherapy
Others
By End User:
Hospitals & Clinics
Diagnostic Centers
Biopharmaceutical Companies
Others
By Region
North America
Latin America
Europe
Asia Pacific
Middle East
Africa About Us:
Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

FBN Expands AI-Powered Platform for Ag Commerce, Financing, and Farm Intelligence
FBN Expands AI-Powered Platform for Ag Commerce, Financing, and Farm Intelligence

National Post

time21 minutes ago

  • National Post

FBN Expands AI-Powered Platform for Ag Commerce, Financing, and Farm Intelligence

Article content SAN MATEO, Calif. — Farmers Business Network (FBN®), the collaborative peer-to-peer farmer network generating farm-level intelligence and a leading marketplace for North America's agricultural sector, announced new investments and platform expansions alongside $50 million in funding to fuel new product lines and AI deployment. Article content The funding will support FBN's mission of powering the prosperity of family farms. Backed by leading investors, including GV (Google Ventures), Temasek, Arteqin, Colle Capital and T Rowe Price, the company builds on its digital platform to simplify agriculture's supply of goods, financing and services, while becoming the farmer's trusted personal AI partner. Article content FBN's farmer network has grown to over 117,000 farms, representing 187 million acres in the U.S. and Canada. Its Amazon-like e-commerce platform offers more than 7,200 products from crops and livestock with direct-to-farm delivery on most orders within 24 to 72 hours. According to recent farmer surveys by Stratus Ag Research, FBN was visited by 35% of farmers when shopping for inputs, and the number of farmers buying inputs online grew 86% vs. 2023. In 2025, more farmers returned to FBN to purchase inputs than ever before, as producers focused on profitability. FBN's Finance platform has now extended nearly $3 billion in total financing to growers. Article content 'Our commitment to putting farmers first means a relentless focus on efficiency and convenience,' said Diego Casanello, CEO of FBN. 'Our goal is to reduce a farm's operating costs 20% or more compared to brick-and-mortar retail. We're working to maximize grower savings and ensure every dollar they spend goes as far as possible.' Article content To better serve its members and build for the future, FBN is evolving to focus on its core digital strengths. This has meant making difficult choices to align its workforce with strategic priorities. These essential changes, while challenging, position FBN to deliver exceptional and sustainable value to its members through innovation. Article content FBN is increasing its strategic investment in advanced AI development. 'Artificial Intelligence is enabling us to provide our farmer members with more personalized and relevant insights,' said Casanello. 'Simultaneously, it offers new tools to automate our marketplace operations, reducing costs and improving the customer experience.' Article content FBN launched 'Norm', the first Large Language Model (LLM) to answer farmer's agronomy questions. The model has been now trained to help farmers with crop marketing related inquiries. Future versions are expected to include personalized agronomy, finance and risk management support. Article content The company is broadening its marketplace offerings – all while improving the fast and convenient service farmers have come to expect and rely on. FBN has significantly expanded its private label product portfolio in 2025 and opened the platform to third-party sellers, allowing them to offer their own brands directly to FBN members via a suite of seller tools and commercial services. Article content Today's announcement includes these expanded product portfolio features: Article content More Private Label and Third-party Crop Protection Products: FBN is enhancing its crop protection, biological and nutrition offerings for major commodity crops like corn, canola, cotton, soybeans, alfalfa and wheat, creating one of the industry's broadest and most trusted portfolios under its Willowood USA ® and Farmers First ® brands, while opening up the platform to more third-party sellers. Canadian Growth: FBN Canada has expanded its wheat crop protection portfolio, added bulk liquid fertilizer and equipment financing, and will open two new distribution centers in 2026. New Seed Platform: FBN is opening the marketplace for third-party seed offers, with leading brands like Seitec Genetics ®, featuring products for corn, soybean, sorghum, alfalfa, and cover crops. Expanding Livestock: FBN's rapidly growing livestock marketplace will continue to expand with new products including feed from Ridley ® & Sweetlix ®, fencing, and a growing assortment of farm & ranch supplies. Article content Farmers Business Network, Inc. (FBN®) is a pioneering digital marketplace and farmer-to-farmer network dedicated to empowering family farmers globally while promoting sustainable agriculture. With over 117,000 members, FBN's Farmers First® promise unites growers and ranchers in their quest to maximize profitability and increase food production. FBN leverages data, AI and direct-to-farm delivery to simplify the agricultural supply chain, boosting convenience and transparency, reducing farm input costs, enhancing access to financing and services, and providing personalized farm insights. Its Gradable® joint-venture helps thousands of farmers adopt and earn rewards for regenerative practices while simplifying the access of regenerative products for the world's leading food companies and grain buyers. Article content Article content Article content Article content

Wall Street hovers near record high ahead of a week packed with potential flashpoints
Wall Street hovers near record high ahead of a week packed with potential flashpoints

CTV News

time21 minutes ago

  • CTV News

Wall Street hovers near record high ahead of a week packed with potential flashpoints

Ed Curran works on the floor at the New York Stock Exchange in New York, Wednesday, July 16, 2025. (AP Photo/Seth Wenig) NEW YORK — U.S. stocks are hanging near record highs Monday after the United States agreed to tax cars and other products coming from the European Union at a 15 per cent rate, lower than U.S. President Donald Trump had earlier threatened. Many details are still to be worked out, however, and Wall Street is heading into a week full of potential flashpoints that could shake markets. The S&P 500 added another 0.1 per cent in early trading after setting an all-time high every day last week. The Dow Jones Industrial Average fell 19 points, or less than 0.1 per cent, as of 9:35 a.m. Eastern time, and the Nasdaq composite is 0.3 per cent higher, coming off its own record. Stocks of U.S. companies that produce and move liquefied natural gas helped drive the market after the head of the European Commission said the bloc's members would buy US$750 billion of U.S. energy products over the next three years. That would help lessen Europe's reliance on Russia for natural gas. Cheniere Energy climbed 4.2 per cent, while NextDecade rose 3.4 per cent. Tesla added 0.2 per cent after its CEO, Elon Musk, said it signed a deal with Samsung Electronics that could be worth more than $16.5 billion to provide chips for the electric-vehicle company. Samsung's stock in South Korea jumped 6.8 per cent. Many more fireworks may be ahead this week. 'This is about as busy as a week can get in the markets,' according to Chris Larkin, managing director, trading and investing, at E-Trade from Morgan Stanley. Hundreds of U.S. companies are lined up and ready to report how much profit they made during the spring, with nearly a third of all the businesses in the S&P 500 index scheduled to deliver updates. That includes market heavyweights Apple, Amazon, Meta Platforms and Microsoft. Those companies have grown so huge that their stock movements can almost solely dictate what the overall S&P 500 index does. Microsoft alone is worth roughly $3.8 trillion, On Wednesday, the U.S. Federal Reserve will announce its latest decision on interest rates. Trump has been loudly and angrily calling for the Fed to cut interest rates, a move that could help give the economy a boost. But Fed Chair Jerome Powell has been insisting that he wants to wait for more data about how Trump's tariffs are affecting the economy and inflation before the Fed makes its next move. Lower interest rates also can give inflation more fuel, and the economy only recently came out of its scarring run where inflation briefly topped nine per cent. The widespread expectation on Wall Street is that the Fed will wait until September to resume cutting interest rates, though a couple of Trump's appointees could dissent in the vote. The Fed has been on hold with interest rates this year since cutting them several times at the end of 2024. This week will also feature several potentially market-moving updates about the economy. On Tuesday will come reports on how confident U.S. consumers are feeling and how many jobs openings U.S. employers were advertising. Wednesday will show the first estimate of how quickly the U.S. economy grew during the spring, and economists expect to see a slowdown from the first three months of the year. On Thursday, the latest measure of inflation that the Federal Reserve prefers to use will arrive. A modest reading could give the Fed more leeway to cut interest rates in the short term, while a hotter-than-expected figure could make it more cautious. And Friday will bring an update on how many more workers U.S. employers hired during June than they fired. Treasury yields held relatively steady in the bond market ahead of all that action. The yield on the 10-year Treasury was remaining at 4.40 per cent, where it was late Friday. The two-year Treasury yield, which more closely tracks expectations for Fed action, edged up to 3.92 per cent from 3.91 per cent. In stock markets abroad, indexes were mixed in Europe amid mostly modest movements following the announcement of the trade deal's framework. Chinese stocks rose as officials from the world's second-largest economy prepare to meet with a U.S. delegation in Sweden for trade talks. Stocks climbed 0.7 per cent in Hong Kong and 0.1 per cent in Shanghai. Indexes were mixed across the rest of Asia, where Japan's Nikkei 225 fell 1.1 per cent for one of the world's bigger losses. Doubts surfaced over what exactly last week's trade truce between Japan and Trump entails, especially Japan's $550 billion pledge of investment in the U.S. Terms of the deal are still being negotiated, and nothing has been formalized in writing, said an official who insisted on anonymity to detail the terms of the talks. The official suggested the goal was for a $550 billion fund to make investments at Trump's direction. ___ AP business writer Elaine Kurtenbach contributed. By Stan Choe

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store